Most recently reported pay: $6.7M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Cramer's week ahead: Expect more volatility as tech earnings, midterms loom
Oct 30, 2026https://www.cnbc.com/2026/10/30/jim-cramer-week-ahead-apple-amd-jobs-report.htmlsentiment +0.50
Amgen Braces for Rising Expenses Ahead of Q3 Results—Is a Profit Squeeze Looming?
Oct 29, 2026https://247wallst.com/investing/2026/10/29/amgen-braces-for-rising-expenses-ahead-of-q3-results-is-a-profit-squeeze-looming/sentiment -0.40
Biotech stocks are surging. How investors can play the new drug innovation boom
Oct 24, 2026https://www.cnbc.com/2026/10/24/biotech-stocks-drug-innovation-rally.htmlsentiment +0.70
Dow rises 1% as earnings gains and lower oil prices lift Wall Street
Oct 20, 2026https://invezz.com/news/2026/10/20/dow-rises-1-as-earnings-gains-and-lower-oil-prices-lift-wall-street/sentiment +0.60
These Consumer Stocks Are Getting a Lift as Investors Rotate Out of Tech
Oct 15, 2026https://www.investopedia.com/market-update-these-consumer-stocks-are-getting-a-lift-as-investors-rotate-out-of-tech-12175680sentiment +0.50
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
Oct 14, 2026https://www.zacks.com/stock/news/3007119/veev-expands-iqvia-partnership-with-clinical-operations-software-suite?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-3007119sentiment +0.10
